Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07798505 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers

StatusRecruiting
PhasePhase 1
SponsorHemab ApS
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Site details revised
  2. Re-verified, no change to tracked fields
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Hemab ApS
5 trials monitored
See 1 trial at risk
The purposes of this clinical study are 1. To see how the new drug (HMB-003) under study is tolerated in healthy volunteers, and if there are any important side effects. 2. To measure the amount of HMB-003 in the body after injection.
Trial Details
NCT Number NCT07798505
Lead Sponsor Hemab ApS
Conditions
(from sponsor)		 Healthy Adult Participants
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov